Genome wide identification of new genes and pathways in patients with both autoimmune thyroiditis and type 1 diabetes

Journal of Autoimmunity

Volumn 60, Issue , 2015, Pages 32-39

  Tomer, Yaron ^a,b   Dolan, Lawrence M ^c   Kahaly, George ^d   Divers, Jasmin ^e   D'Agostino, Ralph B ^e   Imperatore, Giuseppina ^f   Dabelea, Dana ^g   Marcovina, Santica ^h   Black, Mary Helen ⁱ   Pihoker, Catherine ^j   Hasham, Alia ^a   Hammerstad, Sara Salehi ^a   Greenberg, David A ^k   Lotay, Vaneet ^a   Zhang, Weijia ^a   Monti, Maria Cristina ^l   Matheis, Nina ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^g Global Health and Health Disparities   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ KAISER PERMANENTE   (United States)

^j UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^k NATIONWIDE CHILDREN S HOSPITAL   (United States)

^l UNIVERSITY OF PAVIA   (Italy)

more..

Author keywords

Gene; Graves' disease; Hashimoto's thyroiditis; HLA; Type 1 diabetes

Indexed keywords

CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PTPN22 PROTEIN, HUMAN;

ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; B LYMPHOCYTE; CAUCASIAN; CELL CYCLE; COMPUTER PROGRAM; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOLOGY; POLYENDOCRINOPATHY; T LYMPHOCYTE;

ANTIGENS, CD40; B-LYMPHOCYTES; CTLA-4 ANTIGEN; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LINKAGE DISEQUILIBRIUM; POLYENDOCRINOPATHIES, AUTOIMMUNE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; T-LYMPHOCYTES; THYROIDITIS, AUTOIMMUNE;

EID: 84931008634     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2015.03.006     Document Type: Article

References (40)

1. Huber A., Menconi F., Corathers S., Jacobson E.M., Tomer Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr. Rev. 2008, 29:697-725.
2. McKenna M.J., Herskowitz R., Wolfsdorf J.I. Screening for thyroid disease in children with IDDM. Diabetes Care 1990, 13:801-803.
3. Kordonouri O., Klinghammer A., Lang E.B., Gruters-Kieslich A., Grabert M., Holl R.W. Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diabetes Care 2002, 25:1346-1350.
4. Bright G.M., Blizzard R.M., Kaiser D.L., Clarke W.L. Organ-specific autoantibodies in children with common endocrine diseases. J.Pediatr. 1982, 100:8-14.
5. Eisenbarth G.S., Gottlieb P.A. Autoimmune polyendocrine syndromes. N.Engl. J. Med. 2004, 350:2068-2079.
6. McCanlies E., O'Leary L.A., Foley T.P., Kramer M.K., Burke J.P., Libman A., Swan J.S., Steenkiste A.R., McCarthy B.J., Trucco M., Dorman J.S. Hashimoto's thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J.Clin. Endocrinol. Metab. 1998, 83:1548-1551.
7. Dorman J., Kramer M.K., O'Lear L.A., Burke J.P., McCanlies E., McCarthy B.J., Trucco M., Swan J.S., Steenkiste A., Koehler A.N., Foley T.P. Molecular epidemiology of autoimmune thyroid disease. Gac. Med. Mex. 1997, 133(Supp 1):97-103.
8. Tait K.F., Marshall T., Berman J., Carr-Smith J., Rowe B., Todd J.A., Bain S.C., Barnett A.H., Gough S.C. Clustering of autoimmune disease in parents of siblings from the type 1 diabetes Warren repository. Diabet. Med. 2004, 21:358-362.
9. Anaya J.M., Castiblanco J., Tobon G.J., Garcia J., Abad V., Cuervo H., Velasquez A., Angel I.D., Vega P., Arango A. Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J.Autoimmun. 2006, 26:208-214.
10. Levin L., Ban Y., Concepcion E., Davies T.F., Greenberg D.A., Tomer Y. Analysis of HLA genes in families with autoimmune diabetes and thyroiditis. Hum. Immunol. 2004, 65:640-647.
11. Golden B., Levin L., Ban Y., Concepcion E., Greenberg D.A., Tomer Y. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J.Clin. Endocrinol. Metab. 2005, 90:4904-4911.
12. Villano M.J., Huber A.K., Greenberg D.A., Golden B.K., Concepcion E., Tomer Y. Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families. J.Clin. Endocrinol. Metab. 2009, 94:1458-1466.
13. Menconi F., Osman R., Monti M.C., Greenberg D.A., Concepcion E.S., Tomer Y. Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:16899-16903.
14. Dittmar M., Kahaly G.J. Genetics of the autoimmune polyglandular syndrome type 3 variant. Thyroid 2010, 20:737-743.
15. Hamman R.F., Bell R.A., Dabelea D., D'Agostino R.B., Dolan L., Imperatore G., Lawrence J.M., Linder B., Marcovina S., Mayer-Davis E.J., Pihoker C., Rodriguez B.L., Saydah S. The SEARCH for diabetes in the youth study: rationale, findings, and future directions. Diabetes Care 2014, 37:3336-3344. SEARCH for Diabetes in Youth Study Group.
16. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997, 20:1183-1197.
17. Wrensch M., Jenkins R.B., Chang J.S., Yeh R.F., Xiao Y., Decker P.A., Ballman K.V., Berger M., Buckner J.C., Chang S., Giannini C., Halder C., Kollmeyer T.M., Kosel M.L., Lachance D.H., McCoy L., O'Neill B.P., Patoka J., Pico A.R., Prados M., Quesenberry C., Rice T., Rynearson A.L., Smirnov I., Tihan T., Wiemels J., Yang P., Wiencke J.K. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat. Genet. 2009, 41:905-908.
18. Mells G.F., Floyd J.A., Morley K.I., Cordell H.J., Franklin C.S., Shin S.Y., Heneghan M.A., Neuberger J.M., Donaldson P.T., Day D.B., Ducker S.J., Muriithi A.W., Wheater E.F., Hammond C.J., Dawwas M.F., Jones D.E., Peltonen L., Alexander G.J., Sandford R.N., Anderson C.A. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat. Genet. 2011, 43:329-332.
19. Kosoy R., Nassir R., Tian C., White P.A., Butler L.M., Silva G., Kittles R., Alarcon-Riquelme M.E., Gregersen P.K., Belmont J.W., De La Vega F.M., Seldin M.F. Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum. Mutat. 2009, 30:69-78.
20. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
21. Pettitt D.J., Talton J., Dabelea D., Divers J., Imperatore G., Lawrence J.M., Liese A.D., Linder B., Mayer-Davis E.J., Pihoker C., Saydah S.H., Standiford D.A., Hamman R.F. Prevalence of diabetes in U.S. youth in 2009: the SEARCH for diabetes in youth study. Diabetes Care 2014, 37:402-408.
22. Becker K.G., Simon R.M., Bailey-Wilson J.E., Freidlin B., Biddison W.E., McFarland H.F., Trent J.M. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:9979-9984.
23. Santamaria P., Barbosa J.J., Lindstrom A.L., Lemke T.A., Goetz F.C., Rich S.S. HLA-DQB1-associated susceptibility that distinguishes Hashimoto's thyroiditis from Graves' disease in type I diabetic patients. J.Clin. Endocrinol. Metab. 1994, 78:878-883.
24. Wallaschofski H., Meyer A., Tuschy U., Lohmann T. HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III. Horm. Metab. Res. 2003, 35:120-124.
25. Faas S., Trucco M. The genes influencing the susceptibility to IDDM in humans. J.Endocrinol. Invest. 1994, 17:477-495.
26. Birk O.S., Douek D.C., Elias D., Takacs K., Dewchand H., Gur S.L., Walker M.D., van der Zee R., Cohen I.R., Altmann D.M. Arole of Hsp60 in autoimmune diabetes: analysis in a transgenic model. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:1032-1037.
27. Nishida Y., Aida K., Kihara M., Kobayashi T. Antibody-validated proteins in inflamed islets of fulminant type 1 diabetes profiled by laser-capture microdissection followed by mass spectrometry. PLoS One 2014, 9:e107664.
28. Criswell L.A., Pfeiffer K.A., Lum R.F., Gonzales B., Novitzke J., Kern M., Moser K.L., Begovich A.B., Carlton V.E., Li W., Lee A.T., Ortmann W., Behrens T.W., Gregersen P.K. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am. J. Hum. Genet. 2005, 76:561-571.
29. Gjorloff-Wingren A., Saxena M., Williams S., Hammi D., Mustelin T. Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur. J. Immunol. 1999, 29:3845-3854.
30. Vang T., Miletic A.V., Bottini N., Mustelin T. Protein tyrosine phosphatase PTPN22 in human autoimmunity. Autoimmunity 2007, 40:453-461.
31. Granata R., Settanni F., Trovato L., Gallo D., Gesmundo I., Nano R., Gallo M.P., Bergandi L., Volante M., Alloatti G., Piemonti L., Leprince J., Papotti M., Vaudry H., Ong H., Ghigo E. RFamide peptides 43RFa and 26RFa both promote survival of pancreatic beta-cells and human pancreatic islets but exert opposite effects on insulin secretion. Diabetes 2014, 63:2380-2393.
32. Jiang Y., Luo L., Gustafson E.L., Yadav D., Laverty M., Murgolo N., Vassileva G., Zeng M., Laz T.M., Behan J., Qiu P., Wang L., Wang S., Bayne M., Greene J., Monsma F., Zhang F.L. Identification and characterization of a novel RF-amide peptide ligand for orphan G-protein-coupled receptor SP9155. J.Biol. Chem. 2003, 278:27652-27657.
33. Barrett J.C., Clayton D.G., Concannon P., Akolkar B., Cooper J.D., Erlich H.A., Julier C., Morahan G., Nerup J., Nierras C., Plagnol V., Pociot F., Schuilenburg H., Smyth D.J., Stevens H., Todd J.A., Walker N.M., Rich S.S. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 2009, 41:703-707.
34. Stahl E.A., Raychaudhuri S., Remmers E.F., Xie G., Eyre S., Thomson B.P., Li Y., Kurreeman F.A., Zhernakova A., Hinks A., Guiducci C., Chen R., Alfredsson L., Amos C.I., Ardlie K.G., Barton A., Bowes J., Brouwer E., Burtt N.P., Catanese J.J., Coblyn J., Coenen M.J., Costenbader K.H., Criswell L.A., Crusius J.B., Cui J., de Bakker P.I., De Jager P.L., Ding B., Emery P., Flynn E., Harrison P., Hocking L.J., Huizinga T.W., Kastner D.L., Ke X., Lee A.T., Liu X., Martin P., Morgan A.W., Padyukov L., Posthumus M.D., Radstake T.R., Reid D.M., Seielstad M., Seldin M.F., Shadick N.A., Steer S., Tak P.P., Thomson W., van der Helm-Van Mil A.H., van der Horst-Bruinsma I.E., van der Schoot C.E., van Riel P.L., Weinblatt M.E., Wilson A.G., Wolbink G.J., Wordsworth B.P., Wijmenga C., Karlson E.W., Toes R.E., de V N., Begovich A.B., Worthington J., Siminovitch K.A., Gregersen P.K., Klareskog L., Plenge R.M. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 2010, 42:508-514.
35. van Heel D.A., Franke L., Hunt K.A., Gwilliam R., Zhernakova A., Inouye M., Wapenaar M.C., Barnardo M.C., Bethel G., Holmes G.K., Feighery C., Jewell D., Kelleher D., Kumar P., Travis S., Walters J.R., Sanders D.S., Howdle P., Swift J., Playford R.J., McLaren W.M., Mearin M.L., Mulder C.J., McManus R., McGinnis R., Cardon L.R., Deloukas P., Wijmenga C. Agenome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat. Genet. 2007, 39:827-829.
36. Anderson C.A., Boucher G., Lees C.W., Franke A., D'Amato M., Taylor K.D., Lee J.C., Goyette P., Imielinski M., Latiano A., Lagace C., Scott R., Amininejad L., Bumpstead S., Baidoo L., Baldassano R.N., Barclay M., Bayless T.M., Brand S., Buning C., Colombel J.F., Denson L.A., De V.M., Dubinsky M., Edwards C., Ellinghaus D., Fehrmann R.S., Floyd J.A., Florin T., Franchimont D., Franke L., Georges M., Glas J., Glazer N.L., Guthery S.L., Haritunians T., Hayward N.K., Hugot J.P., Jobin G., Laukens D., Lawrance I., Lemann M., Levine A., Libioulle C., Louis E., McGovern D.P., Milla M., Montgomery G.W., Morley K.I., Mowat C., Ng A., Newman W., Ophoff R.A., Papi L., Palmieri O., Peyrin-Biroulet L., Panes J., Phillips A., Prescott N.J., Proctor D.D., Roberts R., Russell R., Rutgeerts P., Sanderson J., Sans M., Schumm P., Seibold F., Sharma Y., Simms L.A., Seielstad M., Steinhart A.H., Targan S.R., van den Berg L.H., Vatn M., Verspaget H., Walters T., Wijmenga C., Wilson D.C., Westra H.J., Xavier R.J., Zhao Z.Z., Ponsioen C.Y., Andersen V., Torkvist L., Gazouli M., Anagnou N.P., Karlsen T.H., Kupcinskas L., Sventoraityte J., Mansfield J.C., Kugathasan S., Silverberg M.S., Halfvarson J., Rotter J.I., Mathew C.G., Griffiths A.M., Gearry R., Ahmad T., Brant S.R., Chamaillard M., Satsangi J., Cho J.H., Schreiber S., Daly M.J., Barrett J.C., Parkes M., Annese V., Hakonarson H., Radford-Smith G., Duerr R.H., Vermeire S., Weersma R.K., Rioux J.D. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 2011, 43:246-252.
37. Howson J.M., Dunger D.B., Nutland S., Stevens H., Wicker L.S., Todd J.A. Atype 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene. Diabetologia 2007, 50:741-746.
38. Huber A.K., Finkelman F.D., Li C.W., Concepcion E., Smith E., Jacobson E., Latif R., Keddache M., Zhang W., Tomer Y. Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease. J.Immunol. 2012, 189:3043-3053.
39. Homann D., Jahreis A., Wolfe T., Hughes A., Coon B., van Stipdonk M.J., Prilliman K.R., Schoenberger S.P., von Herrath M.G. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 2002, 16:403-415.
40. Polychronakos C., Li Q. Understanding type 1 diabetes through genetics: advances and prospects. Nat. Rev. Genet. 2011, 12:781-792.